Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-CDK4/6 Inhibitors: ASCO Rapid Guideline Update Clinical Insights.
| Autor: | Caswell-Jin JL; Stanford University School of Medicine, Stanford, CA., Freedman RA; Dana-Farber Cancer Institute, Boston, MA., Hassett MJ; Dana-Farber Cancer Institute, Boston, MA., Tang H; Stanford University School of Medicine, Stanford, CA., Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA., Somerfield MR; American Society of Clinical Oncology, Alexandria, VA., Giordano SH; MD Anderson Cancer Center, Houston, TX. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | JCO oncology practice [JCO Oncol Pract] 2024 Sep 20, pp. OP2400663. Date of Electronic Publication: 2024 Sep 20. |
| DOI: | 10.1200/OP-24-00663 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|